Selecting a time zone will update the dates above.
Since its preview last December and launch in March, Signals BioDesign™ has rapidly evolved to deliver streamlined DNA cloning workflows for molecular biologists.
Join Revvity for an upcoming webinar to explore the latest advancements in Signals BioDesign and see how the solution continues to evolve to support molecular biology workflows.
In this session, you’ll see the cloning toolkit in action, including Gibson Assembly workflows, and learn how integration with Signals One™ reduces manual data transfer and creates a more connected research experience. We’ll also preview upcoming enhancements as Signals BioDesign continues to expand across the Signals ecosystem.
Register Now
Presenters
Larry Mulcahy, Ph.D.
Product Manager for Biologics in the Signals Suite
Revvity Signals
Larry Mulcahy, PhD is a Product Manager at Revvity leading the development of Signals BioDesign, a molecular biology application that simplifies cloning workflows and enables seamless collaboration for scientists designing DNA and protein constructs. With a PhD from Brown University and postdoctoral research at Harvard Medical School and Northeastern University, Larry brings deep molecular and cell biology expertise to his product strategy. Before joining Revvity, he worked in solution consulting for scientific informatics at Thomson Reuters and Benchling, and now leads biologics product development for Signals One while managing a team delivering new capabilities for biologics customers.
Zev Wisotsky, Ph.D.
Director of Drug Discovery
Biologics Lead at Revvity Signals
Zev Wisotsky, PhD, is Director of Drug Discovery – Biologics Lead at Revvity Signals. A former bench neuroscientist, his background spans molecular biology, biochemistry, and drug discovery. For the past decade he has worked with biotech and pharma teams to simplify complex scientific workflows and bring connected software platforms into modern R&D.